Bortenat 3.5mg Injection
Marketer
Natco Pharma Ltd
Salt Composition
Bortezomib (3.5mg)
Overview Bortenat 3.5mg Injection
Myeloma and mantle cell lymphoma are treated with the injectable medication, Bortezomib 3.5mg. Its mechanism involves inhibiting or reducing the proliferation of cancerous cells. Administration is strictly via injection by a healthcare professional. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Always adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be evident for weeks or months; discontinue only under medical supervision. Common side effects include tiredness, nausea, vomiting, and decreased appetite. Increased fluid intake is often recommended. Due to potential drowsiness and dizziness, avoid driving or operating machinery. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests are vital to monitor blood cell levels, along with heart, liver function, and uric acid. Prior to commencing Bortezomib 3.5mg, inform your doctor about any pre-existing liver, kidney, heart conditions, or bleeding disorders. Report any cognitive symptoms, such as memory impairment or difficulty concentrating, immediately. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment.
Primary Ingredients of Bortenat 3.5mg Injection
No information provided. Please provide the text you wish to be rephrased.
Uses of Bortenat 3.5mg Injection
Myeloma and mantle cell lymphoma
Major Benefits of Bortenat 3.5mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Bortenat 3.5mg Injection:
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
How to use Bortenat 3.5mg Injection:
Administering this medication will be done by your physician or their qualified staff; self-medication is strongly discouraged.
How Bortenat 3.5mg Injection works:
Bortenat 3.5mg Injection is a cancer therapy that inhibits protein degradation within cells. This action elevates intracellular protein levels in cancerous cells, ultimately causing their demise.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Bortenat 3.5mg Injection and alcohol can result in significant sedation.
PregnancyCONSULT YOUR DOCTOR
Using Bortenat 3.5mg Injection during pregnancy poses a confirmed risk to the fetus. Its use is contraindicated except in rare, life-threatening circumstances where the potential benefits clearly outweigh the known hazards. Always seek medical advice before use.
Breast feedingUNSAFE
Administration of Bortenat 3.5mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.
DrivingUNSAFE
Administering Bortenat 3.5mg Injection may induce adverse reactions impairing driving capabilities. These reactions can include fatigue, vertigo, syncope, or visual disturbances.
KidneyCAUTION
For patients with severe kidney impairment, administering Bortenat 3.5mg Injection requires careful consideration. A modified dosage of Bortenat 3.5mg Injection may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Bortenat 3.5mg Injection. Dosage modifications for Bortenat 3.5mg Injection may be necessary. Physician consultation is recommended.
What if you forget to take Bortenat 3.5mg Injection :
Should you forget a scheduled dose of Bortenat 3.5mg Injection, seek advice from your physician.
Facts to Know About Bortenat 3.5mg Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylalanine-based Compounds |
| Developing Habits | No. |
| Type of Therapy | Cancer Drugs |
3,018 People bought this recently